Clinical Test vs. CLIA Compliant
Macrogen’s clinical lab provides clinical sequencing results for the ordering physicians, to help in the diagnosis, treatment, and prevention of cancers and genetic disease. Macrogen’s genomic tests identify specific genes and genetic mutations in a patient’s genome. Next Generation Sequencing services include:
Macrogen clients can choose from three reports to receive their data sets:
Macrogen’s CLIA-Compliant Test is intended to provide CLIA-level sequencing results for pharmaceutical companies, clinical trials or researchers who want more regulated processes. CLIA-compliant tests follow the same workflow as CLIA tests, but are more flexible, providing the information provided—no primary findings are provided unless the customer defines their list(s) of variants of interest.
Like the CLIA Compliant vs. Clinical Test, clients can choose between the basic summary report powered by Omicia Opal or the sequencing stat report. The in-depth curated report with N-of-One is optional.